These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
459 related items for PubMed ID: 26033366
21. Role of Adding Spironolactone and Renal Denervation in True Resistant Hypertension: One-Year Outcomes of Randomized PRAGUE-15 Study. Rosa J, Widimský P, Waldauf P, Lambert L, Zelinka T, Táborský M, Branny M, Toušek P, Petrák O, Čurila K, Bednář F, Holaj R, Štrauch B, Václavík J, Nykl I, Krátká Z, Kociánová E, Jiravský O, Rappová G, Indra T, Widimský J. Hypertension; 2016 Feb; 67(2):397-403. PubMed ID: 26693818 [Abstract] [Full Text] [Related]
26. The effect of renal denervation on resistant hypertension: Meta-analysis of randomized controlled clinical trials. Yao Y, Zhang D, Qian J, Deng S, Huang Y, Huang J. Clin Exp Hypertens; 2016 Feb; 38(3):278-86. PubMed ID: 27018652 [Abstract] [Full Text] [Related]
30. Integrative Blood Pressure Response to Upright Tilt Post Renal Denervation. Howden EJ, East C, Lawley JS, Stickford ASL, Verhees M, Fu Q, Levine BD. Am J Hypertens; 2017 Jun 01; 30(6):632-641. PubMed ID: 28338768 [Abstract] [Full Text] [Related]
33. Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study - a randomized controlled trial. Oliveras A, Armario P, Clarà A, Sans-Atxer L, Vázquez S, Pascual J, De la Sierra A. J Hypertens; 2016 Sep 01; 34(9):1863-71. PubMed ID: 27327441 [Abstract] [Full Text] [Related]
35. Impact of Renal Sympathetic Denervation on Left Ventricular Structure and Function at 1-Year Follow-Up. de Sousa Almeida M, de Araújo Gonçalves P, Branco P, Mesquita J, Carvalho MS, Dores H, Silva Sousa H, Gaspar A, Horta E, Aleixo A, Neuparth N, Mendes M, Andrade MJ. PLoS One; 2016 Sep 01; 11(3):e0149855. PubMed ID: 26934735 [Abstract] [Full Text] [Related]
36. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension. Hering D, Marusic P, Walton AS, Lambert EA, Krum H, Narkiewicz K, Lambert GW, Esler MD, Schlaich MP. Hypertension; 2014 Jul 01; 64(1):118-24. PubMed ID: 24732891 [Abstract] [Full Text] [Related]
37. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension. Donazzan L, Mahfoud F, Ewen S, Ukena C, Cremers B, Kirsch CM, Hellwig D, Eweiwi T, Ezziddin S, Esler M, Böhm M. Clin Res Cardiol; 2016 Apr 01; 105(4):364-71. PubMed ID: 26493305 [Abstract] [Full Text] [Related]
39. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Symplicity HTN-2 InvestigatorsBaker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Road, Central Melbourne, VIC 8008, Australia. murray.esler@bakeridi.edu.au, Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M. Lancet; 2010 Dec 04; 376(9756):1903-9. PubMed ID: 21093036 [Abstract] [Full Text] [Related]